- Home
- ACI vs ASND Comparison
ACI vs ASND Comparison
Compare ACI & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACI
- ASND
- Stock Information
- Founded
- ACI 1860
- ASND 2006
- Country
- ACI United States
- ASND Denmark
- Employees
- ACI N/A
- ASND N/A
- Industry
- ACI Food Chains
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- ACI Consumer Staples
- ASND Health Care
- Exchange
- ACI Nasdaq
- ASND Nasdaq
- Market Cap
- ACI 12.2B
- ASND 9.9B
- IPO Year
- ACI 2020
- ASND 2015
- Fundamental
- Price
- ACI $21.98
- ASND $155.86
- Analyst Decision
- ACI Buy
- ASND Strong Buy
- Analyst Count
- ACI 12
- ASND 14
- Target Price
- ACI $23.85
- ASND $201.79
- AVG Volume (30 Days)
- ACI 9.0M
- ASND 417.3K
- Earning Date
- ACI 04-15-2025
- ASND 05-01-2025
- Dividend Yield
- ACI 2.73%
- ASND N/A
- EPS Growth
- ACI N/A
- ASND N/A
- EPS
- ACI 1.78
- ASND N/A
- Revenue
- ACI $79,930,900,000.00
- ASND $376,478,932.00
- Revenue This Year
- ACI $2.35
- ASND $58.89
- Revenue Next Year
- ACI $2.44
- ASND $75.85
- P/E Ratio
- ACI $12.34
- ASND N/A
- Revenue Growth
- ACI 0.97
- ASND 36.34
- 52 Week Low
- ACI $17.00
- ASND $111.09
- 52 Week High
- ACI $22.05
- ASND $169.37
- Technical
- Relative Strength Index (RSI)
- ACI 60.94
- ASND 51.63
- Support Level
- ACI $20.66
- ASND $161.50
- Resistance Level
- ACI $22.05
- ASND $161.91
- Average True Range (ATR)
- ACI 0.48
- ASND 5.94
- MACD
- ACI 0.02
- ASND -1.25
- Stochastic Oscillator
- ACI 94.96
- ASND 47.14
About ACI Albertsons Companies Inc.
Albertsons is the second largest supermarket operator in the United States with more than 2,200 stores across a variety of banners. About 80% of the firm's sales stem from non-perishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers and pharmacies at about 20% and 75% of its store locations, respectively. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of outstanding shares.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.